9.90
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast
The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $9.90. The highest analyst price target is $0.00, and the lowest is $0.00.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00
(-100.00% Downside)
Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 49.40 | Neutral |
STOCH(9,6) | 48.93 | Neutral |
STOCHRSI(14) | 0.00 | Neutral |
MACD(12,26) | 0.00 | Neutral |
ADX(14) | 0.00 | Neutral |
William %R | -68.42 | Neutral |
CCI(14) | -0.3623 | Neutral |
Buy: 0
Sell: 0
Neutral: 7
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
9.5225
Buy
|
9.7987
Buy
|
MA20 |
7.8718
Buy
|
0.00
Buy
|
MA50 |
3.1487
Buy
|
0.00
Buy
|
MA100 |
1.5744
Buy
|
0.00
Buy
|
MA200 |
0.7872
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, BBOT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 0 signaling Sell signals and 7 Neutral signals. This might be a good time to open fresh positions on BBOT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 49.4 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.93 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that BBOT is oversold. This suggests that BBOT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -0.3623 indicates that BBOT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):